Autoimmunity Against INS-IGF2 Protein Expressed in Human Pancreatic Islets

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2013 Aug 13

PMID 23935095

Citations 19

Authors

Norio Kanatsuna

Jalal Taneera

Fariba Vaziri-Sani

Nils Wierup

Helena Elding Larsson

Ahmed Delli

Hanna Skarstrand

Alexander Balhuizen

Hedvig Bennet

Donald F Steiner

Carina Torn

Malin Fex

Ake Lernmark

Affiliations

Soon will be listed here.

Abstract

Insulin is a major autoantigen in islet autoimmunity and progression to type 1 diabetes. It has been suggested that the insulin B-chain may be critical to insulin autoimmunity in type 1 diabetes. INS-IGF2 consists of the preproinsulin signal peptide, the insulin B-chain, and eight amino acids of the C-peptide in addition to 138 amino acids from the IGF2 gene. We aimed to determine the expression of INS-IGF2 in human pancreatic islets and autoantibodies in newly diagnosed children with type 1 diabetes and controls. INS-IGF2, expressed primarily in beta cells, showed higher levels of expression in islets from normal compared with donors with either type 2 diabetes (p = 0.006) or high HbA1c levels (p < 0.001). INS-IGF2 autoantibody levels were increased in newly diagnosed patients with type 1 diabetes (n = 304) compared with healthy controls (n = 355; p < 0.001). Displacement with cold insulin and INS-IGF2 revealed that more patients than controls had doubly reactive insulin-INS-IGF2 autoantibodies. These data suggest that INS-IGF2, which contains the preproinsulin signal peptide, the B-chain, and eight amino acids of the C-peptide may be an autoantigen in type 1 diabetes. INS-IGF2 and insulin may share autoantibody-binding sites, thus complicating the notion that insulin is the primary autoantigen in type 1 diabetes.

Citing Articles

Novel Molecular Networks and Regulatory MicroRNAs in Type 2 Diabetes Mellitus: Multiomics Integration and Interactomics Study.

Khokhar M, Roy D, Tomo S, Gadwal A, Sharma P, Purohit P JMIR Bioinform Biotechnol. 2024; 3(1):e32437.

PMID: 38935970 PMC: 11135235. DOI: 10.2196/32437.

Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells.

van Tienhoven R, Kracht M, van der Slik A, Thomaidou S, Wolters A, Giepmans B Diabetologia. 2023; 66(5):884-896.

PMID: 36884057 PMC: 10036285. DOI: 10.1007/s00125-023-05882-y.

Understanding Insulin in the Age of Precision Medicine and Big Data: Under-Explored Nature of Genomics.

Cook T, Wilstermann A, Mitchell J, Arnold N, Rajasekaran S, Bupp C Biomolecules. 2023; 13(2).

PMID: 36830626 PMC: 9953665. DOI: 10.3390/biom13020257.

Found in Translation: Novel Insights Into Type 1 Diabetes and β-Cell Biology.

Russ H, Davidson H Diabetes. 2021; 70(10):2185-2186.

PMID: 34593539 PMC: 8576502. DOI: 10.2337/dbi21-0031.

Large parental differences in chromatin organization in pancreatic beta cell line explaining diabetes susceptibility effects.

Jian X, Felsenfeld G Nat Commun. 2021; 12(1):4338.

PMID: 34267199 PMC: 8282625. DOI: 10.1038/s41467-021-24635-2.

References

Kulmala P, Savola K, Petersen J, Vahasalo P, Karjalainen J, Lopponen T . Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest. 1998; 101(2):327-36. PMC: 508571. DOI: 10.1172/JCI119879. View

Arif S, Tree T, Astill T, Tremble J, Bishop A, Dayan C . Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest. 2004; 113(3):451-63. PMC: 324541. DOI: 10.1172/JCI19585. View

Falorni A, Nikoshkov A, Laureti S, Grenback E, Hulting A, Casucci G . High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 1995; 80(9):2752-5. DOI: 10.1210/jcem.80.9.7673419. View

Devendra D, Liu E, Eisenbarth G . Type 1 diabetes: recent developments. BMJ. 2004; 328(7442):750-4. PMC: 381328. DOI: 10.1136/bmj.328.7442.750. View

Kanatsuna N, Papadopoulos G, Moustakas A, Lenmark A . Etiopathogenesis of insulin autoimmunity. Anat Res Int. 2012; 2012:457546. PMC: 3335545. DOI: 10.1155/2012/457546. View

Knight R, Kronenberg D, Zhao M, Huang G, Eichmann M, Bulek A . Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidity. Diabetes. 2012; 62(1):205-13. PMC: 3526019. DOI: 10.2337/db12-0315. View

Mire-Sluis A, Das R, Lernmark A . The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia. 2000; 43(10):1282-92. DOI: 10.1007/s001250051524. View

Diaz J, Wilkin T . Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies. Clin Chem. 1988; 34(2):356-9. View

Bulek A, Cole D, Skowera A, Dolton G, Gras S, Madura F . Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol. 2012; 13(3):283-9. PMC: 3378510. DOI: 10.1038/ni.2206. View

10.

Carlsson A, Axelsson I, Borulf S, Bredberg A, LINDBERG B, Sjoberg K . Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics. 1999; 103(6 Pt 1):1248-52. DOI: 10.1542/peds.103.6.1248. View

11.

Schlosser M, Mueller P, Achenbach P, Lampasona V, Bingley P . Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2β. Diabetes Care. 2011; 34(11):2410-2. PMC: 3198291. DOI: 10.2337/dc11-1161. View

12.

Weksberg R, Shen D, Fei Y, Song Q, Squire J . Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet. 1993; 5(2):143-50. DOI: 10.1038/ng1093-143. View

13.

Vardi P, Ziegler A, MATHEWS J, Dib S, Keller R, Ricker A . Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 1988; 11(9):736-9. DOI: 10.2337/diacare.11.9.736. View

14.

Wooldridge L, Ekeruche-Makinde J, van den Berg H, Skowera A, Miles J, Tan M . A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem. 2011; 287(2):1168-77. PMC: 3256900. DOI: 10.1074/jbc.M111.289488. View

15.

Stentz F, Wright R, Kitabchi A . A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies. Diabetes. 1982; 31(12):1128-31. DOI: 10.2337/diacare.31.12.1128. View

16.

Levy-Marchal C, Bridel M, Koch M, Tichet J, Czernichow P, SODOYEZ J . Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children. Diabetes Care. 1991; 14(1):61-3. DOI: 10.2337/diacare.14.1.61. View

17.

Wilkin T, Palmer J, Kurtz A, Bonifacio E, Diaz J . The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987. Diabetologia. 1988; 31(7):449-50. DOI: 10.1007/BF00271590. View

18.

Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E . The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity. 2011; 44(5):394-405. DOI: 10.3109/08916934.2010.540604. View

19.

Elfving A, Lindberg B, Nystrom L, Sundkvist G, Lernmark A, Ivarsson S . Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age. Autoimmunity. 2003; 36(4):227-31. DOI: 10.1080/0891693031000141040. View

20.

Falorni A, Ortqvist E, Persson B, Lernmark A . Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods. 1995; 186(1):89-99. DOI: 10.1016/0022-1759(95)00139-2. View